Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CENNX vs. AMCPX: which is better?

Bottom line

CENNX vs AMCPX: the short answer

CENNX (Centerstone Investors Fund) and AMCPX (Amcap Fund) are both mutual funds.

AMCPX is cheaper at 0.64% vs 2.15% — a difference of $151 a year per $10,000 invested.

Over five years, AMCPX returned +9.2% a year vs +0.9% for CENNX (reporting dates differ).

AMCPX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

CENNX vs AMCPX side by side

CENNXAMCPX
TypeMutual fundMutual fund
Fund familyFidelityAmerican Funds (Capital Group)
CategoryLarge BlendLarge Blend
Expense ratio2.15%0.64%
Annual cost per $10k$215$64
10-yr cost on $10k (prospectus)$2,612$1,327
Max front load0%5.75%
12b-1 fee1%0.24%
1-yr return−1.0%+11.0%
5-yr return (annualized)+0.9%+9.2%
10-yr return (annualized)—+12.0%
Best quarter+16.9%+23.2%
Worst quarter−26.3%−19.5%
Net assets (fund)—$97.2B
Number of holdings—121
Portfolio turnover14%36%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CENNX and AMCPX share none of their top holdings.

CENNX top 10

    AMCPX top 10

    1. Broadcom Inc — 7.58%
    2. Nvidia Corp — 7.04%
    3. Amazon.com Inc — 6.21%
    4. Alphabet Inc — 5.77%
    5. Microsoft Corp — 5.63%
    6. Eli Lilly And Co — 4.59%
    7. Meta Platforms Inc — 3.84%
    8. Taiwan Semiconductor Manufacturing Co Ltd — 3.36%
    9. Transdigm Group Inc — 2.29%
    10. Vertex Pharmaceuticals Inc — 2.14%

    FAQ

    What is the difference between CENNX and AMCPX?
    CENNX (Centerstone Investors Fund) and AMCPX (Amcap Fund) are both mutual funds. AMCPX is cheaper at 0.64% vs 2.15% — a difference of $151 a year per $10,000 invested.
    Which is cheaper, CENNX or AMCPX?
    AMCPX has the lower expense ratio (0.64%).
    Should I own both CENNX and AMCPX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.